← Back to Patent Explorer
US4428940A Expired / Lapsed US ⏱️ 0.0 years remaining

Anti-hypertensive compounds and compositions

Assignee: Beecham Group PLC
•
Filing: 1982-03-09
•
Granted: 1984-01-31
•
Expires: 2002-03-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compounds of formula (I): ##STR1## or a pharmaceutically acceptable salt thereof, wherein m is 0 to 3; n is 1 to 5; R 1 is hydrogen, or C 1-6 alkyl; R 2 is hydrogen, C 1-4 alkyl, --(CH 2 ) p --NH 2 wherein p is 1 to 4, or --NHCOR, wherein R 5 is C 1-4 alkyl; R 3 is hydrogen or C 1-6 alkyl; R 4 is C 1-4 alkyl, C 1-4 alkoxy, halogen or CF 3 ; and X is CH 2 or S. having useful pharmacological activity, compositions containing them, and a process for their preparation.

Inventors

  • 👤 Roger E. Markwell

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 22:57
CPC Classifications
C; C07; C07D; C07D307/00; C07D307/77; C07D307/78; C07D307/79; A; A61; A61P; A61P43/00; A61P9/00; A61P9/12; C07D307/80; C07K; C07K5/00; C07K5/02; C07K5/022; C07K5/0222; A61K; A61K38/00

Claims Analysis

Total Claims: 16
Claim 1
Independent Claim 89 words
A compound of formula (I), ##STR19## or a pharmaceutically acceptable salt thereof, wherein: m is 0 to 3; n is 1 to 5; R 1 is hydrogen or C 1-6 alkyl; R 2 is hydrogen, C 1-4 alkyl, --(CH 2 ) p -NH 2 wherein p is 1 to 4, or --NHCOR 5 wherein R 5 is C 1-4 alkyl; R 3 is hydrogen or C 1-6 alkyl R 4 is C 1-4 alkyl, C 1-4 alkoxy, halogen or CF 3 ; and x is CH 2 or S.
Claim 2
Dependent Claim 89 words
A compound of formula (I), ##STR19## or a pharmaceutically acceptable salt thereof, wherein: m is 0 to 3; n is 1 to 5; R 1 is hydrogen or C 1-6 alkyl; R 2 is hydrogen, C 1-4 alkyl, --(CH 2 ) p -NH 2 wherein p is 1 to 4, or --NHCOR 5 wherein R 5 is C 1-4 alkyl; R 3 is hydrogen or C 1-6 alkyl R 4 is C 1-4 alkyl, C 1-4 alkoxy, halogen or CF 3 ; and x is CH 2 or S.
Claim 3
Dependent Claim 21 words
A compound according to claim 1, wherein the dihydrobenzofuranyl moiety is bonded to the rest of the structure at the 2-position.
Claim 4
Dependent Claim 52 words
A compound according to claim 2, having the formula (I)' ##STR20## or a pharmaceutically acceptable salt thereof, wherein: n is 1 or 2 to 5 R 1 and R 3 are the same or different and each is hydrogen or C 1-4 alkyl; and R 2 is hydrogen or C 1-4 alkyl.
Claim 5
Dependent Claim 29 words
A compound according to claim 3, wherein: n is 2 to 5; R 1 is C 1-4 alkyl; R 2 is C 1-4 alkyl; and R 3 is hydrogen.
Claim 6
Dependent Claim 27 words
A compound according to claim 1 wherein the asymmetric centres of the part structures of formulae (A) and (B) (indicated *): ##STR21## are in the S configuration.
Claim 7
Dependent Claim 9 words
N-[N-[[2-(2,3-Dihydro-2-benzofuranyl)-1-(ethoxycarbonyl)]ethyl]-(S)-alanyl]-(S)-proline or N-[N-[[4-(2,3-Dihydro-2-benzofuranyl)-1-(ethoxycarbonyl)]butyl]-(S)-alanyl]-(S)-proline or a pharmaceutically acceptable salt thereof.
Claim 8
Dependent Claim 9 words
N-[N-[[2-(2,3-Dihydro-2-benzofuranyl)-1-(ethoxycarbonyl)]ethyl]-(S)-alanyl]-(S)-proline or N-[N-[[4-(2,3-Dihydro-2-benzofuranyl)-1-(ethoxycarbonyl)]butyl]-(S)-alanyl]-(S)-proline or a pharmaceutically acceptable salt thereof.
Claim 9
Dependent Claim 25 words
A pharmaceutical composition for the treatment of hypertension which comprises an effective amount of a compound according to claim 1 and a pharmaceutically acceptable carrier.
Claim 10
Dependent Claim 25 words
A method of treatment of hypertension in mammals including humans comprising administering to the sufferer a therapeutically effective amount of a composition of claim 7.
Claim 11
Dependent Claim 26 words
A compound of claim 1, wherein R 2 is hydrogen, C 1-4 alkyl or --(CH 2 ) p -NH 2 wherein p is 1 to 4.
Claim 12
Dependent Claim 84 words
A compound of the formula (II): ##STR22## wherein m is 0 to 3; n is 1 to 5; R 1 is hydrogen or C 1-6 alkyl; R 2 is hydrogen, C 1-4 alkyl, --(CH 2 ) p --NH 2 wherein p is 1 to 4, or --NHCOR 5 wherein R 5 is C 1-4 alkyl; R 3 is hydrogen or C 1-6 alkyl; R 4 is C 1-4 alkyl, C 1-4 alkoxy, halogen or CF 3 ; and X is CH 2 or S.
Claim 13
Dependent Claim 84 words
A compound of the formula (II): ##STR22## wherein m is 0 to 3; n is 1 to 5; R 1 is hydrogen or C 1-6 alkyl; R 2 is hydrogen, C 1-4 alkyl, --(CH 2 ) p --NH 2 wherein p is 1 to 4, or --NHCOR 5 wherein R 5 is C 1-4 alkyl; R 3 is hydrogen or C 1-6 alkyl; R 4 is C 1-4 alkyl, C 1-4 alkoxy, halogen or CF 3 ; and X is CH 2 or S.
Claim 14
Dependent Claim 21 words
A compound of the formula (III): ##STR23## wherein m, n, R 1 and R 4 are as defined in claim 10.
Claim 15
Dependent Claim 33 words
A compound of the formula (V): ##STR24## wherein R 1 is C 1-6 alkyl and m, n and R 4 are as defined in claim 10, and Q is a carbonyl protecting group.
Claim 16
Dependent Claim 16 words
A compound of claim 12, wherein the carbonyl protecting group Q is a ketal or thioketal.

References Cited (Backward Citations)

US4192878A Cited
US4282235A Cited
US4308392A Cited
US4371699A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-01-30 1987-08-01 1988-01-31 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-01-30 1991-08-01 1992-01-31 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-01-30 1995-08-01 1996-01-31 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag